Drugs / 2-mercaptoethane sulfonate Na
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03172052 | Aug 2017 → Jun 2019 | — | Assiut University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2-mercaptoethane sulfonate Na | “MESNA (2-mercaptoethane sulfonate Na)” NCT03172052 ↗ |
| Known as | MESNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03172052 ↗ |
| Route | Other | “will be injected into the pleural cavity through the chest tube” NCT03172052 ↗ |